Search by Drug Name or NDC

NDC 70934-0594-30 Valsartan and Hydrochlorothiazide 25; 160 mg/1; mg/1 Details

Valsartan and Hydrochlorothiazide 25; 160 mg/1; mg/1

Valsartan and Hydrochlorothiazide is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Denton Pharma, Inc. DBA Northwind Pharmaceuticals. The primary component is HYDROCHLOROTHIAZIDE; VALSARTAN.

MedlinePlus Drug Summary

Hydrochlorothiazide is used alone or in combination with other medications to treat high blood pressure. Hydrochlorothiazide is used to treat edema (fluid retention; excess fluid held in body tissues) caused by various medical problems, including heart, kidney, and liver disease and to treat edema caused by using certain medications including estrogen and corticosteroids. Hydrochlorothiazide is in a class of medications called diuretics ('water pills'). It works by causing the kidneys to get rid of unneeded water and salt from the body into the urine. High blood pressure is a common condition and when not treated, can cause damage to the brain, heart, blood vessels, kidneys and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.

Related Packages: 70934-0594-30
Last Updated: 05/12/2024
MedLinePlus Full Drug Details: Hydrochlorothiazide

Combination product This product contains two medications, valsartan and hydrochlorothiazide. Please see the individual monographs for information about each of the medications contained in this product.

Related Packages: 70934-0594-30
Last Updated: 05/12/2024
MedLinePlus Full Drug Details: Valsartan and Hydrochlorothiazide

Product Information

NDC	70934-0594
Product ID	70934-594_d8da094e-927d-4e0f-e053-2995a90a4c63
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Valsartan and Hydrochlorothiazide
Proprietary Name Suffix	n/a
Non-Proprietary Name	Valsartan and Hydrochlorothiazide
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET
Route	ORAL
Active Ingredient Strength	25; 160
Active Ingredient Units	mg/1; mg/1
Substance Name	HYDROCHLOROTHIAZIDE; VALSARTAN
Labeler Name	Denton Pharma, Inc. DBA Northwind Pharmaceuticals
Pharmaceutical Class	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA203145
Listing Certified Through	n/a

Package

NDC 70934-0594-30 (70934059430)

Pricing Information	N/A
NDC Package Code	70934-594-30
Billing NDC	70934059430
Package	30 TABLET in 1 BOTTLE, PLASTIC (70934-594-30)
Marketing Start Date	2020-03-05
NDC Exclude Flag	N